|
82
|
305
|
2q6gA |
Crystal structure of sars-cov main protease h41a mutant in complex with an n-terminal substrate |
|
83
|
306
|
5wkmA |
2.25 a resolution structure of mers 3cl protease in complex with piperidine-based peptidomimetic inhibitor 21 |
|
92
|
301
|
5wfiA |
X-ray structure of mhv plp2 (cys1716ser) catalytic mutant in complex with free ubiquitin |
|
87
|
315
|
5tl6B |
Crystal structure of sars-cov papain-like protease in complex with the c-terminal domain of human isg15 |
|
88
|
316
|
5tl7B |
Crystal structure of sars-cov papain-like protease in complex with c-terminal domain mouse isg15 |
|
83
|
306
|
5n5oA |
Structure of sars coronavirus main protease in complex with the alpha-ketoamide (s)-n-benzyl-3-((s)-2-cinnamamido-3-cyclopropylpropanamido)-2-oxo-4-((s)-2-oxopyrrolidin-3-yl)butanamide (cinnamoyl-cyclopropylalanine-glnlactam-co-co-nh-benzyl) |
|
23
|
133
|
5c8sA |
Crystal structure of the sars coronavirus nsp14-nsp10 complex with functional ligands sah and gpppa |
|
88
|
300
|
5c5oA |
Structure of sars-3cl protease complex with a phenyl-beta-alanyl (s,r)-n-decalin type inhibitor |
|
57
|
167
|
5hihA |
Crystal structure of the macro domain in middle-east respiratory syndrome coronavirus |
|
54
|
167
|
5holA |
The crystal structure of the mers-cov macro domain with adp-ribose |
|
0
|
8
|
4zuhC |
Complex structure of pedv 3clpro mutant (c144a) with a peptide substrate. |
|
91
|
306
|
4yogA |
Hku4-3clpro bound to non-covalent inhibitor 3b |
|
31
|
115
|
5f22B |
C-terminal domain of sars-cov nsp8 complex with nsp7 |
|
86
|
317
|
5e6jA |
Structure of sars plpro bound to a lys48-linked di-ubiquitin activity based probe |
|
91
|
306
|
4yoiA |
Structure of hku4 3clpro bound to non-covalent inhibitor 1a |
|
58
|
165
|
5dusA |
Crystal structure of mers-cov macro domain in complex with adp-ribose |
|
100
|
378
|
4yptA |
X-ray structural of three tandemly linked domains of nsp3 from murine hepatitis virus at 2.60 angstroms resolution |
|
84
|
306
|
4yo9A |
Hku4 3clpro unbound structure |
|
81
|
306
|
4wy3A |
Structure of sars-3cl protease complex with a phenylbenzoyl (r,s)-n-decalin type inhibitor |
|
84
|
317
|
4wurA |
The crystal structure of the mers-cov papain-like protease (c111s) with human ubiquitin |
|
76
|
306
|
4twwA |
Structure of sars-3cl protease complex with a bromobenzoyl (s,r)-n-decalin type inhibitor |
|
85
|
306
|
4twyA |
Structure of sars-3cl protease complex with a phenylbenzoyl (s,r)-n-decalin type inhibitor |
|
82
|
324
|
4r3dA |
Crystal structure of mers coronavirus papain like protease |
|
73
|
305
|
4ovzA |
X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases |
|
80
|
312
|
4ow0A |
X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases |
|
61
|
252
|
4ovzB |
X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases |
|
95
|
317
|
4m0wA |
Crystal structure of sars-cov papain-like protease c112s mutant in complex with ubiquitin |
|
81
|
316
|
4mm3B |
Crystal structure of sars-cov papain-like protease plpro in complex with ubiquitin aldehyde |
|
90
|
303
|
4mdsA |
Discovery of n-(benzo[1,2,3]triazol-1-yl)-n-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (sars-cov) 3clpro inhibitors: identification of ml300 and non-covalent nanomolar inhibitors with an induced-fit binding |
|
82
|
300
|
4hi3A |
Crystal structure of dimeric r298a mutant of sars coronavirus main protease |
|
91
|
292
|
3r24A |
Crystal structure of nsp10/nsp16 complex of sars coronavirus" if possible |
|
34
|
121
|
3r24B |
Crystal structure of nsp10/nsp16 complex of sars coronavirus" if possible |
|
84
|
306
|
3m3sA |
Crystal structure of sars-cov main protease asn214ala mutant with authorize n-terminus |
|
78
|
306
|
3m3vA |
Sars-cov main protease triple mutant sti/a with two n-terminal additional residue (gly-ser) |
|
90
|
312
|
3mj5A |
Severe acute respiratory syndrome-coronavirus papain-like protease inhibitors: design, synthesis, protein-ligand x-ray structure and biological evaluation |
|
74
|
307
|
3m3tA |
Sars-cov main protease monomeric arg298ala mutant with n-terminal additional residues (gly-ser) |
|
62
|
301
|
3iwmA |
The octameric sars-cov main protease |
|
79
|
299
|
3fzdA |
Mutation of asn28 disrupts the enzymatic activity and dimerization of sars 3clpro |
|
82
|
299
|
3f9fA |
Crystal structure of the f140a mutant of sars-coronovirus 3c-like protease at ph 6.0 |
|
76
|
300
|
3f9gA |
Crystal structure of the f140a mutant of sars-coronovirus 3c-like protease at ph 6.5 |
|
64
|
297
|
3f9eA |
Crystal structure of the s139a mutant of sars-coronovirus 3c-like protease |
|
77
|
299
|
3f9hA |
Crystal structure of the f140a mutant of sars-coronovirus 3c-like protease at ph 7.6 |
|
24
|
100
|
3ebnA |
A special dimerization of sars-cov main protease c-terminal domain due to domain-swapping |
|
88
|
317
|
3e9sA |
A new class of papain-like protease/deubiquitinase inhibitors blocks sars virus replication |
|
81
|
302
|
3eajA |
Crystal structure of sars-cov main protease quadruple mutant stif/a with two molecules in one asymmetric unit |
|
23
|
110
|
3ee7A |
Crystal structure of sars-cov nsp9 g104e |
|
85
|
306
|
3ea8A |
Crystal structure of sars-cov main protease triple mutant sti/a in space group c2 |
|
81
|
301
|
3ea9A |
Crystal structure of sars-cov main protease quadruple mutant stif/a with one molecule in one asymmetric unit |
|
80
|
305
|
3ea7A |
Crystal structure of sars-cov main protease triple mutant sti/a in space group p21 |
|
80
|
305
|
3e91A |
Crystal structure of sars-cov mpro mutant in p21 at ph6.9 |
